Search results
Results From The WOW.Com Content Network
The size of Lonza Group Ltd (VTX:LONN), a CHF22b large-cap, often attracts investors seeking a reliable investment in the stock market. Market participants who are conscious of risk tend to search ...
After Lonza Group Ltd's (VTX:LONN) earnings announcement in December 2018, analysts seem cautiously optimistic, as a...
lonza.com. Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development ...
Lonza's Biologics unit produces monoclonal antibodies and drug conjugates, and comprises approximately 45% of its annual sale Swiss pharma firm Lonza's profit falls less than feared, shares rise ...
On 5 July 2007, SWX announced that Ciba Specialty Chemicals, Lonza Group, Givaudan, SGS and one of the two classes of shares of Swatch Group would leave the SMI as of 24 September 2007 leaving 20 securities in the index. [14] September 2009: Nobel Biocare and Bâloise replaced by Lonza Group and SGS. [15] June 2010: Swiss Life replaced by ...
Investor relations (IR) is a "strategic management responsibility that is capable of integrating finance, communication, marketing and securities law compliance to enable the most effective two-way communication between a company, the financial community, and other constituencies, which ultimately contributes to a company's securities achieving fair valuation."
For this year, Lonza said it was still targeting "low to mid-teens" sales growth, when excluding currency swings, as well as an improvement in the core EBITDA margin that is consistent with a 2024 ...
Language links are at the top of the page across from the title.